Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Xtant Medical Holdings Inc (XTNT) AMEX

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 7,110
  • Shares Outstanding, K 12,190
  • Annual Sales, $ 59,350 K
  • Annual Income, $ -2,170 K
  • 36-Month Beta 0.88
  • Price/Sales 0.08
  • Price/Book 0.00
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.65
  • Most Recent Earnings N/A on N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.50 +4.00%
on 01/09/17
0.85 -38.82%
on 01/11/17
-0.08 (-13.33%)
since 12/16/16
3-Month
0.45 +15.56%
on 11/16/16
0.97 -46.39%
on 10/19/16
-0.51 (-49.51%)
since 10/18/16
52-Week
0.45 +15.56%
on 11/16/16
3.75 -86.13%
on 03/16/16
-2.19 (-80.81%)
since 01/15/16

Most Recent Stories

More News
XTNT Announces Closing of Registered Direct Offering

Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, today has announced the closing of...

XTNT Announces Registered Direct Offering

Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, today has announced that it has entered...

Xtant Medical Receives FDA Clearance for the Xsert(TM) Lumbar Expandable Interbody System

Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that the U.S. Food and Drug Administration (FDA) has cleared...

Xtant Medical Closes Rights Offering for Gross Proceeds of $3.8 Million

Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, announced today the closing of its...

Xtant Medical Announces First Surgical Cases of Xspan(TM) Laminoplasty Fixation System

Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced the first surgical cases of the Xspan Laminoplasty Fixation...

Xtant Medical Announces Adjustment to Subscription Price of Rights Offering

Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, announced today that it has adjusted...

Xtant Medical Receives Approval of Compliance Plan from NYSE MKT

Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, today announced that the NYSE MKT LLC...

Xtant Medical Announces Commencement of Subscription Period for Previously Announced Rights Offering

Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, announced today that it has commenced...

Xtant Medical Reminds Shareholders That Rights Offering Ownership Day is Tuesday, October 18, 2016 at 4:00 PM ET

Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, provides stockholders and convertible...

Xtant Medical Holdings, Inc. to Report Third Quarter 2016 Financial Results on November 7, 2016

Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that it will release its financial results for the period...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Business Summary

Xtant Medical Holdings, Inc. develops, manufactures and markets biologics products. The Company's product used in an applications which includes enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery...

See More

Support & Resistance

2nd Resistance Point 0.59
1st Resistance Point 0.56
Last Price 0.52
1st Support Level 0.50
2nd Support Level 0.47

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.